Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis
Clinical and Molecular Hepatology · 01.07.2024 · 30 (3) · 561-576
DOI: 10.3350/cmh.2023.0384 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.07.2024. Verfasst von Juchul Hwang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea. Hauptthemen laut MEDLINE: Obesity, Bariatric Surgery, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare, National Research Foundation of Korea.
Abstract (Originalsprache)
Background/Aims: Bariatric intervention has been reported to be an effective way to improve metabolic dysfunction-associated steatotic liver disease (MASLD) in obese individuals. The current systemic review aimed to assess the changes in MRI-determined hepatic proton density fat fraction (MRI-PDFF) and nonalcoholic fatty liver disease activity score (NAS) after bariatric surgery or intragastric balloon/gastric banding in MASLD patients with obesity.
Methods
We searched various databases including PubMed, OVID Medline, EMBASE, and Cochrane Library. Primary outcomes were the changes in intrahepatic fat on MRI-PDFF and histologic features of metabolic dysfunction-associated steatohepatitis (MASH).
Results
Thirty studies with a total of 3,134 patients were selected for meta-analysis. Bariatric intervention significantly reduced BMI (ratio of means, 0.79) and showed 72% reduction of intrahepatic fat on MRI-PDFF at 6 months after bariatric intervention (ratio of means, 0.28). Eight studies revealed that NAS was reduced by 60% at 3–6 months compared to baseline, 40% at 12–24 months, and 50% at 36–60 months. Nineteen studies revealed that the proportion of patients with steatosis decreased by 44% at 3–6 months, 37% at 12–24 months, and 29% at 36–60 months; lobular inflammation by 36% at 12–24 months and 51% at 36–60 months; ballooning degeneration by 38% at 12–24 months; significant fibrosis (≥F2) by 18% at 12–24 months and by 17% at 36–60 months after intervention.
Conclusions
Bariatric intervention significantly improved MRI-PDFF and histologic features of MASH in patients with obesity. Bariatric intervention might be the effective alternative treatment option for patients with MASLD who do not respond to lifestyle modification or medical treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea.
- Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
- Department of Gastroenterology and Hepatology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
- National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.
- Biostatistics Collaboration Team, Research Institute, National Cancer Center, Goyang, Korea.
- Department of Internal Medicine, Hanyang University School of Medicine, Seoul, Korea.
Förderung
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
- National Research Foundation of Korea
- National Cancer Center
Zitieren
APA
Hwang, J., Hwang, H., Shin, H., Kim, B. H., Kang, S. H., Yoo, J. J., Choi, M. Y., Lee, D. E., Jun, D. W., & Cho, Y. (2024). Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis. Clinical and Molecular Hepatology, 30(3), 561-576. https://doi.org/10.3350/cmh.2023.0384
Vancouver
Hwang J, Hwang H, Shin H, Kim BH, Kang SH, Yoo JJ, et al. Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis. Clinical and Molecular Hepatology. 2024;30(3):561-576. doi:10.3350/cmh.2023.0384
BibTeX
@article{Hwang2024,
author = {Hwang, Juchul and Hwang, Hyeyoung and Shin, Hyunjae and Kim, Bo Hyun and Kang, Seong Hee and Yoo, Jeong-Ju and Choi, Mi Young and Lee, Dong Eun and Jun, Dae Won and Cho, Yuri},
title = {Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis},
journal = {Clinical and Molecular Hepatology},
year = {2024},
volume = {30},
number = {3},
pages = {561--576},
doi = {10.3350/cmh.2023.0384}
}
EUVIMED